Document Detail


Control of ocular blood flow.
MedLine Citation:
PMID:  2409404     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The eye has a dual vascular supply. The uveal vessels are distributed within the choroid, the ciliary body, and the iris; and the retinal vessels within the inner parts of the retina. The vascularization of the uvea is very rich and the blood flow is high, which stabilizes the temperature of the eye. The vascularization of the retina is relatively sparse, which is an obvious advantage for the optics. The perfusion pressure in the eye can be defined as the local arterial blood pressure minus the intraocular pressure. Reductions in perfusion pressure, caused by increments in intraocular pressure, or reductions in mean arterial pressure reduce the blood flow in the choroid. In the retina, there are efficient autoregulatory mechanisms that prevent changes in flow within a wide range of perfusion pressures. Stimulation of the cervical sympathetic chain causes vasoconstriction in the uvea, with near-maximal effects as 10 Hz. The sympathetic nerves are not activated during moderate hemorrhage. They apparently prevent overperfusion and breakdown of intraocular barriers under conditions of acute elevation of the arterial blood pressure. Electrical stimulation of the oculomotor nerve causes cholinergic vasoconstriction in the anterior uvea. Near-maximal vasoconstriction is obtained between 10 and 20 Hz. In conscious animals, muscarinic blockade causes vasodilatation in the iris, indicating that there is a basal traffic in the vasomotor fibers of the oculomotor nerve. Electrical stimulation of the facial nerve causes vasodilatation in the uvea that cannot be prevented by muscarinic blockade: near-maximal vasodilatation is obtained between 10 and 20 Hz.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
A Bill; S F Nilsson
Related Documents :
11858614 - Effects of topical natural ergot alkaloids on intraocular pressure and aqueous humor dy...
22581454 - Efficacy and safety of switching to travoprost/timolol fixed-combination therapy from l...
3315374 - Studies of nontraumatic osteonecrosis. manometric and histologic studies of the femoral...
3364174 - Repeated 50 burn/180 degree argon laser trabeculoplasty.
20736024 - Flecainide inhibits the stimulatory effect of veratridine on the response of airway mec...
17056674 - Cardiovascular responses to oxygen inhalation after hemorrhage in anesthetized rats: hy...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  7 Suppl 3     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  1985  
Date Detail:
Created Date:  1985-07-30     Completed Date:  1985-07-30     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  S96-102     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Blood Pressure
Electric Stimulation
Eye / blood supply*
Facial Nerve / physiology
Humans
Oculomotor Nerve / physiology
Prostaglandins / physiology
Regional Blood Flow
Retinal Vessels / physiology
Sympathetic Nervous System / physiology
Uvea / blood supply
Vasoactive Intestinal Peptide / physiology
Grant Support
ID/Acronym/Agency:
5 ROI EY 00475-17/EY/NEI NIH HHS
Chemical
Reg. No./Substance:
0/Prostaglandins; 37221-79-7/Vasoactive Intestinal Peptide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Autonomic regulation of the pulmonary circulation.
Next Document:  A mathematical model of tumour-induced capillary growth.